PLTR•November 17, 2026 at 9:10 AM UTCSoftware & Services

Palantir's Blowout Quarter Fails to Impress as TCV Growth Slows to 6%

Read source article

What happened

Palantir reported yet another exceptional quarter with revenue up 96% year over year and U.S. commercial revenue surging 148% to $984 million, surpassing U.S. government revenue for the first time. However, total contract value growth decelerated sharply to 6% from 49% a quarter earlier, a slowdown the company attributes to shorter-duration sovereign AI contracts. The stock sank despite the strong headline numbers, reflecting investor unease with the deceleration and the lack of disclosed dollar values from sovereign deals. The latest DeepValue master report already flagged that sovereign AI remains mostly a narrative without visible backlog scale, and the market is pricing in sustained hypergrowth with no margin of safety at $175.40. This new data point reinforces the WAIT rating, as the next phase of growth still requires concrete evidence of international and sovereign monetization.

Implication

The investment case remains a WAIT: while operational execution is exceptional, the stock's premium valuation leaves little room for error. The TCV slowdown, even if explained by contract duration, signals that the next leg of growth is not yet secured. Investors should watch for non-U.S. revenue share improvement and disclosed sovereign contract values in coming quarters; failure to deliver could compress the multiple significantly. Conversely, a sustained reacceleration in billings and large-deal formation could justify a more constructive stance. For now, an attractive entry level is near $145, with upside contingent on sovereign monetization delivering on the narrative.

Thesis delta

The core thesis remains unchanged: Palantir has a real moat and exceptional operating metrics, but the stock is fully valued and requires repeated upside surprises. The new TCV data point underscores the fragility of the sovereign AI narrative, as growth in contract value is not yet translating into headline revenue or backlog. This marginally increases the conviction in the WAIT rating, but does not warrant a downgrade given the strength in U.S. commercial.

Confidence

High